Related Experiment Video

Updated: Jul 18, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Antisense oligonucleotide against the Ca channel beta subunit decreases L-type Ca current in rat ventricular myocytes

Rob N Leach1, Fabien Brette, Clive H Orchard

  • 1Institute of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK.

Biochemical and Biophysical Research Communications
|December 5, 2006
PubMed

Insights

Endogenous beta subunits are crucial for trafficking the alpha1 subunit of L-type calcium channels to the cell membrane in cardiac myocytes, significantly impacting calcium current amplitude.

Area of Science:

  • Cardiovascular physiology
  • Molecular cardiology
  • Ion channel biophysics

Background:

  • The precise function of endogenous beta subunits in native cardiac L-type calcium channels remains largely undefined.
  • Understanding beta subunit roles is critical for elucidating cardiac electrophysiology and calcium handling.

Purpose of the Study:

  • To investigate the functional impact of endogenous beta subunits on L-type calcium channel alpha1 subunit expression and activity in rat cardiac ventricular myocytes.
  • To determine the role of beta subunits in the trafficking and function of L-type calcium channels within the native cardiac environment.

Main Methods:

  • Isolated rat cardiac ventricular myocytes were cultured with antisense or scrambled oligonucleotides to inhibit beta subunit expression.
  • Immunolabeling was employed to assess alpha1 subunit expression and subcellular localization.
  • Whole-cell patch-clamp electrophysiology was used to measure L-type calcium current (ICaL) characteristics.

Main Results:

  • Inhibition of beta subunit expression led to increased perinuclear alpha1 subunit staining, indicating impaired trafficking.
  • Antisense treatment resulted in a significant decrease in L-type calcium current amplitude.
  • A minor rightward shift in the activation curve and I-V relation was observed, without affecting inactivation kinetics.

Conclusions:

  • Endogenous beta subunits play a vital role in the proper trafficking of the L-type calcium channel alpha1 subunit to the myocyte cell membrane.
  • Beta subunits are key determinants of L-type calcium current amplitude in native cardiac ventricular myocytes.
  • These findings highlight the importance of beta subunit-alpha1 subunit interactions for cardiac function.

More Related Videos

Primary Culture of Adult Rat Heart Myocytes11:44

Primary Culture of Adult Rat Heart Myocytes

Published on: June 16, 2009

Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current06:22

Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current

Published on: November 3, 2020

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...